Skip to main content
Advertisement
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Minneapolis City Hospital
      • Pitié-Salpêtrière Hospital
      • Tufts Medical Center
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
    • On My Mind
    • Podcast Archive
      • → Circulation on the Run, FIT Edition
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association

Search for author "Tuo Zhang"

  • Modify Search
  • Create Alert
  • Save Search

33 Results

Type a term to search within all articles in this journal: e.g., stem cell
Content Type
Select types of content to include in the results.
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
e.g., 08/01/2017
e.g., 08/01/2017
Format Results
  • You have accessRestricted access
    Cartilage Oligomeric Matrix Protein Inhibits Vascular Smooth Muscle Calcification by Interacting With Bone Morphogenetic Protein-2Novelty and Significance
    Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong and Xian Wang
    Circulation Research. 2011;108:917-928, originally published April 14, 2011
    https://doi.org/10.1161/CIRCRESAHA.110.234328
    Download PDF
  • You have access
    Cartilage Oligomeric Matrix Protein Inhibits Vascular Smooth Muscle Calcification by Interacting With Bone Morphogenetic Protein-2Novelty and Significance
    Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong, Xian Wang
    Circulation Research April 2011, 108 (8) 917-928; DOI: https://doi.org/10.1161/CIRCRESAHA.110.234328
    Figure 1.
    Figure 1.
    By Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong and Xian Wang
    COMP protein level is decreased in calcifying VSMCs and arteries. A, Representative Western blot and quantitative analysis of COMP protein in bovine V...Show More
    COMP protein level is decreased in calcifying VSMCs and arteries. A, Representative Western blot and quantitative analysis of COMP protein in bovine VSMCs cultured in calcifying medium containing 10 mmol/L β-GP for 3, 5, and 7 days. Relative COMP protein level was normalized to that of β-actin and expressed as means±SEM from 3 independent experiments performed in duplicate (bottom). *P<0.05. B, COMP protein level in A7r5 cells exposed to 5 mmol/L CaCl2 for 3, 6, 9, and 12 days. C, Representative Western blot and quantitative analysis of COMP protein in abdominal aortas from sham-operated or rats with CRF (5/6 nephrectomization plus high phosphate diet) at time of euthanasia (n=7 per group). *P<0.05 vs sham control. D, COMP expression in rat abdominal aortas periadventitially treated with 0.2 mol/L NaCl or CaCl2 (n=5 per group). *P<0.05.Show Less
  • You have access
    Cartilage Oligomeric Matrix Protein Inhibits Vascular Smooth Muscle Calcification by Interacting With Bone Morphogenetic Protein-2Novelty and Significance
    Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong, Xian Wang
    Circulation Research April 2011, 108 (8) 917-928; DOI: https://doi.org/10.1161/CIRCRESAHA.110.234328
    Figure 2.
    Figure 2.
    By Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong and Xian Wang
    COMP deficiency aggravates VSMCs calcification in vitro. A, Quantitative analysis of calcium deposition. A7r5 cells were transfected with scramble siR...Show More
    COMP deficiency aggravates VSMCs calcification in vitro. A, Quantitative analysis of calcium deposition. A7r5 cells were transfected with scramble siRNA or COMP siRNA 48 hours before incubation with calcifying medium containing 5 mmol/L CaCl2 for an additional 12 days. B, A7r5 cells were stained for mineralization by Alizarin red S. Scale bar, 20 μm. C, Identification of COMP deficiency in VSMCs of COMP knockout mice or littermate wild-type c57 mice by Western blot analysis. D, Quantitative analysis of calcium deposition in VSMCs from COMP knockout or wild-type mice in response to high phosphate for 12 days. Values are expressed as means±SEM from 3 independent experiments. *P<0.05. E, Representative Alizarin red S staining of calcium nodule. Scale bar, 20 μm.Show Less
  • You have access
    Cartilage Oligomeric Matrix Protein Inhibits Vascular Smooth Muscle Calcification by Interacting With Bone Morphogenetic Protein-2Novelty and Significance
    Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong, Xian Wang
    Circulation Research April 2011, 108 (8) 917-928; DOI: https://doi.org/10.1161/CIRCRESAHA.110.234328
    Figure 3.
    Figure 3.
    By Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong and Xian Wang
    COMP overexpression inhibits VSMC calcification in vitro. Quantification of calcium deposition and Alizarin red S staining in bovine VSMCs (A and B) o...Show More
    COMP overexpression inhibits VSMC calcification in vitro. Quantification of calcium deposition and Alizarin red S staining in bovine VSMCs (A and B) or rat A7r5 cells (C and D). Bovine VSMCs were infected with 5 multiplicities of infection of Ad-GFP or Ad-COMP for 48 hours before β-GP stimulation for an additional 7 days. Similarly, A7r5 cells were infected with 50 multiplicities of infection of Ad-GFP or Ad-COMP, followed by administration of 5 mmol/L CaCl2 for 12 days. The results are means±SEM from 3 independent experiments performed in duplicate. *P<0.05. The reddish/purple staining indicates mineral deposition. Scale bar, 20 μm.Show Less
  • You have access
    Cartilage Oligomeric Matrix Protein Inhibits Vascular Smooth Muscle Calcification by Interacting With Bone Morphogenetic Protein-2Novelty and Significance
    Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong, Xian Wang
    Circulation Research April 2011, 108 (8) 917-928; DOI: https://doi.org/10.1161/CIRCRESAHA.110.234328
    Figure 4.
    Figure 4.
    By Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong and Xian Wang
    Overexpression of COMP retards aortic calcification. A, Rat abdominal aortas were infected periadventitially with Ad-GFP or Ad-COMP. After 3 days, abd...Show More
    Overexpression of COMP retards aortic calcification. A, Rat abdominal aortas were infected periadventitially with Ad-GFP or Ad-COMP. After 3 days, abdominal aortas were cut into rings and cultured in vitro in DMEM or calcifying medium containing 3.8 mmol/L PO43− for 6 days. A, Quantification of calcium deposition. B, von Kossa and hematoxylin/eosin staining of mineral nodules. Values are means±SEM (n=6 for each group). *P<0.05. C, Rat abdominal arteries were treated with 0.2 mol/L CaCl2 for 10 minutes before periadventitial infection with Ad-GFP or Ad-COMP. After 7 days, rats were euthanized and abdominal arteries were isolated and analyzed for calcium deposition (C) and von Kossa staining (D). *P<0.05. Scale bar, 10 μm.Show Less
  • You have access
    Cartilage Oligomeric Matrix Protein Inhibits Vascular Smooth Muscle Calcification by Interacting With Bone Morphogenetic Protein-2Novelty and Significance
    Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong, Xian Wang
    Circulation Research April 2011, 108 (8) 917-928; DOI: https://doi.org/10.1161/CIRCRESAHA.110.234328
    Figure 5.
    1 of 2
    Figure 5.
    By Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong and Xian Wang
    COMP negatively regulates osteochondrogenic transition of VSMCs. Quantification of relative mRNA level of osteogenic-related marker genes (A) and smoo...Show More
    COMP negatively regulates osteochondrogenic transition of VSMCs. Quantification of relative mRNA level of osteogenic-related marker genes (A) and smooth muscle marker genes (B) in the absence or presence of COMP silencing. *P<0.05 vs scramble siRNA. C, Quantitative real-time PCR analysis of osteogenic markers in VSMCs incubated with calcifying medium containing CaCl2 for 12 days. VSMCs were infected with Ad-GFP or Ad-COMP, respectively, before CaCl2 administration. *P<0.05. D, Representative Western blot and quantification analysis of expression of osteogenic markers (Runx2 and BMP-2) and smooth muscle lineage markers (α-actin and SM 22α) in rat abdominal aortic rings treated with 3.8 mmol/L Pi for 3 days after infection with Ad-GFP or Ad-COMP (n=5 per group). *P<0.05. E, Representative Western blot and quantification of osteogenic and SMC lineage protein expression in CaCl2-treated rat abdominal arteries infected with Ad-GFP or Ad-COMP at 7 days (n=5 per group). *P<0.05.Show Less
  • You have access
    Cartilage Oligomeric Matrix Protein Inhibits Vascular Smooth Muscle Calcification by Interacting With Bone Morphogenetic Protein-2Novelty and Significance
    Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong, Xian Wang
    Circulation Research April 2011, 108 (8) 917-928; DOI: https://doi.org/10.1161/CIRCRESAHA.110.234328
    Figure 6.
    Figure 6.
    By Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong and Xian Wang
    COMP inhibits BMP-2 osteogenic signaling. A, Quantitative real-time PCR analysis of osteogenic gene expression in VSMCs transfected with scramble or C...Show More
    COMP inhibits BMP-2 osteogenic signaling. A, Quantitative real-time PCR analysis of osteogenic gene expression in VSMCs transfected with scramble or COMP siRNA in the presence or absence of soluble BMPR-IA (1 mg/L). B, Relative expression of endogenous BMP-2 mRNA in VSMCs in response to treatment with increasing amounts of exogenous BMP-2 for 24 hours. *P<0.05 compared with control. C, Western blot analysis of BMP-2–induced Smad1/5/8 activation and downstream Runx2/Msx2 expression in VSMC. A7r5 cells were transfected with scramble or COMP-specific siRNA. Forty-eight hours later, Smad1/5/8 activation was detected in VSMCs stimulated by recombinant human BMP-2 (500 μg/L) for an additional 30 minutes. Expression level of Runx2 and Msx2 were assessed in VSMCs stimulated by BMP-2 for 24 hours. D, Western blot and quantitative analysis of BMP-2–induced Smad1/5/8 activation. A7r5 cells were infected with Ad-GFP or Ad-COMP 48 hours before challenge with recombinant human BMP-2 (500 μg/L) for 30 minutes. E and F, Relative mRNA (E) and protein (F) level of BMP-2–induced osteogenic transcriptional factors Runx2, Msx2, and osteocalcin (OCN). A7r5 cells were infected with Ad-GFP or Ad-COMP for 48 hours before treatment with recombinant BMP-2 (500 μg/L) for 3 hours (for mRNA) or 24 hours (for protein), respectively.Show Less
  • You have access
    Cartilage Oligomeric Matrix Protein Inhibits Vascular Smooth Muscle Calcification by Interacting With Bone Morphogenetic Protein-2Novelty and Significance
    Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong, Xian Wang
    Circulation Research April 2011, 108 (8) 917-928; DOI: https://doi.org/10.1161/CIRCRESAHA.110.234328
    Figure 7.
    Figure 7.
    By Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong and Xian Wang
    COMP associates with BMP-2 and inhibits BMP-2 receptor binding. A, Co-IP assay in HEK293 cell line stably transfected with COMP. Recombinant human BMP...Show More
    COMP associates with BMP-2 and inhibits BMP-2 receptor binding. A, Co-IP assay in HEK293 cell line stably transfected with COMP. Recombinant human BMP-2 (500 μg/L) was added and incubated for 12 hours. Left, Whole-cell lysates of HEK293 cells were immunoprecipitated with anti–BMP-2 antibody or control IgG before protein A agarose beads, then analyzed by Western blot (WB) with anti-COMP antibody. Right, HEK293 cell extracts were immunoprecipitated with anti-COMP antibodies or control IgG and analyzed by Western blot with anti–BMP-2 antibody. B, Co-IP assay of rat VSMCs and aortas. Left, VSMCs lysates or vascular extracts were incubated with anti–BMP-2 antibody or control IgG, then protein A agarose, and then analyzed by Western blot with anti-COMP antibody. Right, VSMCs lysates or vascular extracts were immunoprecipitated with anti-COMP antibodies or control IgG and analyzed by Western blot with anti–BMP-2 antibody. C, Solid phase binding assay. Various amounts of recombinant human BMP-2 or purified COMP underwent 10% SDS-PAGE and were incubated with purified COMP or human recombinant BMP-2. Anti-COMP or anti–BMP-2 antibodies were used for subsequent detection. BSA served as negative control. D, BMP-2 selectively binds to the C-terminal domain of COMP. Top, Schematic structure of COMP constructs used to map those domains (N-terminal, EGF-like, type III, and C-terminal) that bind to BMP-2. Presence or absence of binding between COMP domains and BMP-2 is indicated with + or −, respectively. Bottom, β-Galactosidase activity was used to test the interaction between the C-terminal domain of COMP and BMP-2. Three independent yeast transformants for each pair of plasmids were transferred onto a nitrocellulose membrane, and β-galactosidase activity was determined. E, GST pull-down assay. Purified fusion protein of GST–N terminus, GST-EGF, GST–C terminus, and GST–C type III of COMP were immobilized on GSH-sepharose beads and incubated with purified BMP-2. Proteins trapped by GST fusion protein were examined by immunoblotting with anti–BMP-2 antibodies. Purified BMP-2 (first lane) was used as a positive control. Arrow indicates BMP-2 band. F, Effect of increasing concentrations of unlabeled COMP on the binding of 125I-labeled BMP-2 by VSMC membrane–bound receptors. 125I-labeled BMP-2 was incubated in the absence or presence of unlabeled COMP with VSMC membranes at 4°C for 24 hours. Values are expressed as percentages of specific binding determined in the absence or presence of unlabeled COMP. Each point is the average of triplicate determinations. The fitted curve was obtained by use of GraphPad Prism 5.0. G, COMP retarded the competitive inhibition of unlabeled BMP-2 to 125I-labeled BMP-2 receptor binding. Unlabeled BMP-2 (0.462 nmol/L) competitively inhibited 125I–BMP-2 receptor binding, whereas unlabeled COMP (6.5 nmol/L) significantly abolished the effect. Each point is the average of triplicate determinations. *P<0.05.Show Less
  • You have access
    Cartilage Oligomeric Matrix Protein Inhibits Vascular Smooth Muscle Calcification by Interacting With Bone Morphogenetic Protein-2Novelty and Significance
    Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong, Xian Wang
    Circulation Research April 2011, 108 (8) 917-928; DOI: https://doi.org/10.1161/CIRCRESAHA.110.234328
    Figure 8.
    Figure 8.
    By Yaoyao Du, Yue Wang, Li Wang, Bo Liu, Qingyun Tian, Chuan-ju Liu, Tao Zhang, Qingbo Xu, Yi Zhu, Oldberg Ake, Yongfen Qi, Chaochu Tang, Wei Kong and Xian Wang
    COMP is degraded, whereas BMP-2 is increased, in uremic radial arteries of patients with end-stage renal failure (CRF). Representative Western blot an...Show More
    COMP is degraded, whereas BMP-2 is increased, in uremic radial arteries of patients with end-stage renal failure (CRF). Representative Western blot analysis and quantification of COMP protein, as well as BMP-2 and Runx2, are shown. CRF: uremic patients who underwent arterial venous fistular operation (n=4 to 6); control: CHD (n=8) patients who underwent coronary artery bypass grafting, without complications of diabetes and chronic kidney disease. Results are means±SEM normalized to that of β-actin. *P<0.05.Show Less
  • You have access
    Transcriptional Silencing of the Death Gene BNIP3 by Cooperative Action of NF-κB and Histone Deacetylase 1 in Ventricular Myocytes
    James Shaw, Tong Zhang, Marek Rzeszutek, Natalia Yurkova, Delphine Baetz, James R. Davie, Lorrie A. Kirshenbaum
    Circulation Research December 2006, 99 (12) 1347-1354; DOI: https://doi.org/10.1161/01.RES.0000251744.06138.50
    By James Shaw, Tong Zhang, Marek Rzeszutek, Natalia Yurkova, Delphine Baetz, James R. Davie and Lorrie A. Kirshenbaum
    Figure 1. HDAC inhibition disrupts p65-mediated repression of Bnip3 gene transcription. Panel A, Postnatal ventricular myocytes were transfected with...Show More
    Figure 1. HDAC inhibition disrupts p65-mediated repression of Bnip3 gene transcription. Panel A, Postnatal ventricular myocytes were transfected with a Bnip3 luciferase reporter with and without a p65 NF-κB expression vector in the presence and absence of trichostatin A (TSA, 10 nM). Panel B, IKKβ-mediated NF-κB activation represses Bnip3 gene transcription in ventricular myocytes. Postnatal ventricular myocytes were infected with adenoviruses encoding IKKβ (IKKβ) in the presence and absence TSA (10 nM). Endogenous Bnip3 in ventricular myocytes was examined by semiquantitative RT-PCR. Data were normalized to house keeping control gene L32. Control cells (CNTL) were transfected with the eukaryotic expression vector pcDNA3 (panel A) or infected with control adenovirus (panel B). Data are expressed as mean ± S.E. (P<0.05). Experiments were repeated at least n=6 with independent culture conditions using replicates of n=3 for each condition tested, *=statistically different from CNTL; ‡=statistically different from p65; N.S.=not significant.Show Less

Pages

  • 1
  • 2
  • 3
  • 4
  • Next Page
Back to top

Selected Facets

Selected Facets

  • Molecular Medicine (Article Type)

Publication Date

Publication date

  • 2008-2012 9
  • 2003-2007 15
  • 1978-2002 9

Subject

Subject

  • Animal models of human disease 9
  • Apoptosis 15
  • Cell signalling/signal transduction 24
  • Gene expression 15
  • Gene regulation 15
  • Hypertension - basic studies 9
  • Ischemic biology - basic studies 15
  • Other Vascular biology 9
  • Physiological and pathological control of gene expression 15
  • Smooth muscle proliferation and differentiation 9
  • Show More
  • Show Less

Content Type

Resource Type

  • Articles 3
  • Tables & Figures 30
Advertisement
Advertisement

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2017 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured